All news

Medicinal cannabis users could drive after taking the drug after MPs vote

Users of medicinal cannabis would be able to drive while taking the drug after MPs voted to change proposed laws aimed at tightening restrictions on drug driving.

Medicinal cannabis access a challenge for WA patients despite legalisation last year

West Australian patients are finding it almost impossible to obtain medicinal cannabis more than eight months after it was legalised, advocates say.

Crystal structures of agonist-bound human cannabinoid receptor CB1

The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Δ9-tetrahydrocannabinol (Δ9-THC).

Germany is the next major marijuana market

The G-20 summit is currently taking place in Hamburg, Germany and marijuana has made its presence known. Although some of the expected discussion topics include climate change, security and trade, we think medical marijuana will be a topic that takes center stage.

Zynerba Pharma's failed cannabidiol gel trial has upside for rival GW Pharma

GW Pharma’s Epidiolex could be the U.S.’s first cannabis-derived drug.

Arkansas patients fear losing social security benefits over medical marijuana

Last week, the Arkansas Department of Health started accepting applications for medical marijuana registry identification cards. These cards will be issued to qualifying patients and caregivers 30 days before the state allows dispensaries to open, which will likely occur early next year.

Scientists lay the groundwork for a reliable marijuana breathalyzer

NIST researchers have measured a fundamental physical property of the primary psychoactive compound in marijuana.

Chelsea Leyland's big crusade for cannabis

The DJ, who was diagnosed with epilepsy at 13 years old, opens up about ditching western drugs for CBD oil.

Medicinal cannabis bill: 'It's a useful discussion to have'

The minister responsible for drug reform will give his initial support to a member's bill legalising medicinal cannabis

Botanix speaks on Australia's lack of infrastructure to run large clinical trials

Botanix, an Australian company, is developing the first new acne treatment in 20 years. The treatment involves using synthetic cannabis oil to treat pimples.